Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this clinical trial is to determine the anti-tumor activity of APO866 in patients with advanced cutaneous melanoma.
Critère d'inclusion
- The medical condition is advanced cutaneous melanoma stage IV or unresectable stage III